237 related articles for article (PubMed ID: 2796362)
1. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
[TBL] [Abstract][Full Text] [Related]
2. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
4. Benefits of glucose and oxygen in multidose cold cardioplegia.
Doherty NE; Turocy JF; Geffin GA; O'Keefe DD; Titus JS; Daggett WM
J Thorac Cardiovasc Surg; 1992 Feb; 103(2):219-29. PubMed ID: 1735987
[TBL] [Abstract][Full Text] [Related]
5. Long-term preservation of explanted hearts perfused with L-aspartate-enriched cardioplegic solution. Improved function, metabolism, and ultrastructure.
Choong YS; Gavin JB; Buckman J
J Thorac Cardiovasc Surg; 1992 Feb; 103(2):210-8. PubMed ID: 1735986
[TBL] [Abstract][Full Text] [Related]
6. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
Ledingham SJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
[TBL] [Abstract][Full Text] [Related]
7. Cardioplegic protection of hearts with pre-arrest ischaemic injury: effect of glucose, aspartate, and lactobionate.
Choong YS; Gavin JB; Cottier DS
Thorac Cardiovasc Surg; 1995 Dec; 43(6):331-7. PubMed ID: 8775858
[TBL] [Abstract][Full Text] [Related]
8. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
Tachibana H
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of myocardial protective effects between GIK solution and St. Thomas solution by use of canine isolated heart-lung preparations].
Ina H; Yasuda I
Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2318-27. PubMed ID: 2693545
[TBL] [Abstract][Full Text] [Related]
10. Effect of oxygenation and consequent pH changes on the efficacy of St. Thomas' Hospital cardioplegic solution.
von Oppell UO; King LM; Du Toit EF; Owen P; Reichart B; Opie LH
J Thorac Cardiovasc Surg; 1991 Sep; 102(3):396-404. PubMed ID: 1908927
[TBL] [Abstract][Full Text] [Related]
11. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
[TBL] [Abstract][Full Text] [Related]
12. L-aspartate improves the functional recovery of explanted hearts stored in St. Thomas' Hospital cardioplegic solution at 4 degrees C.
Choong YS; Gavin JB
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):510-7. PubMed ID: 2308369
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
Baker JE; Boerboom LE; Olinger GN
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
[TBL] [Abstract][Full Text] [Related]
14. Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.
Boggs BR; Torchiana DF; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Newell JB; Daggett WM
J Thorac Cardiovasc Surg; 1987 Jun; 93(6):838-46. PubMed ID: 3573797
[TBL] [Abstract][Full Text] [Related]
15. Effect of an oxygen-enriched solution and multiple dosing of antegrade crystalloid cardioplegic solution on myocardial metabolism during coronary artery bypass graft operations.
Downey RS; Weintraub WS; Jones EL; Conn RB; Ash T
J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1148-7. PubMed ID: 1405675
[TBL] [Abstract][Full Text] [Related]
16. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart.
Coetzee A; Kotzé J; Louw J; Lochner A
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):259-69. PubMed ID: 3945093
[TBL] [Abstract][Full Text] [Related]
17. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia.
Amrani M; Gray CC; Smolenski RT; Goodwin AT; London A; Yacoub MH
Circulation; 1997 Nov; 96(9 Suppl):II-274-9. PubMed ID: 9386110
[TBL] [Abstract][Full Text] [Related]
18. Recovery of the neonatal heart after normothermic ischemia. Effect of oxygen and catalase.
Zweng TN; Lynch MJ; Bove EL; Fox MH; Iannettoni MD; Bolling SF; Gallagher KP
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):326-36. PubMed ID: 1992243
[TBL] [Abstract][Full Text] [Related]
19. New pluronic-free perfluorocarbon cardioplegia improves myocardial oxygenation.
Johnson DL; Greene PS; Gott VL; Gardner TJ
Circulation; 1988 Nov; 78(5 Pt 2):III153-7. PubMed ID: 3180395
[TBL] [Abstract][Full Text] [Related]
20. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts.
Myers CL; Weiss SJ; Kirsh MM; Shepard BM; Shlafer M
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):281-9. PubMed ID: 3945095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]